Tuesday, August 23, 2016
Global Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022
Do you like this story?
Upsetting Growth in Cancer Prevalence
to Determine the Growth of Biopsy Devices Market: Biopsy Guidance Systems
Segment to Reach Worth USD 981 Mn by 2022
According
to the latest publication by Credence Research, Inc. “Global Biopsy Devices
Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016
- 2022,” the biopsy devices market was
valued at USD 1,792.37 Mn in 2015, and is
expected to reach USD 2,829.31 Mn by
2022, expanding at a CAGR of 6.8% from 2016 to 2022.
Market Insights
With
more than 100 types, cancer is among the most lethal and widely prevalent
chronic diseases prevalent worldwide. The increasing awareness regarding the
risk factors and possible risk factors associated with cancer and the alarming
disease prevalence has led to the growth in demand for advanced cancer
diagnostic methods and diagnosis products. Biopsy is the most common and widely
accepted cancer diagnostic method that offers closest to accurate diagnosis and
disease confirmation.
This
study on global biopsy devices market analyzes the product market by guidance
systems, biopsy needles, needle based biopsy guns, biopsy forceps and others.
Among these, biopsy guidance systems segment is the current market leader in
terms of revenue share and is anticipated to reach USD 981 Mn by 2022.
Streamlining of workflow, accuracy in sample extraction and procurement of high
resolution images of the targeted abnormalities are the prime advantages
offered by guided biopsies. Towards the end of the forecast period, needle
based biopsy guns segment is anticipated to surpass the market position of
guidance systems.
In
terms of geography, North America is the largest regional market for biopsy
devices. Higher awareness among the patient population, advanced healthcare
infrastructure and defined reimbursement policies, along with high cancer
prevalence are the major contributors to the dominance of North America in the
global biopsy devices market. Additionally, Asia-Pacific is expected to
progress at faster CAGR due to factors such growing incidence of cancer,
rapidly aging population, and burgeoning adoption of technically advanced
solutions along with growing purchasing power of the general population.
This
market is characterized by rapid expansion of product portfolio. Consolidative
activities constitute a major expansion strategy of large market players. C.R.
Bard, Hologic, Cook Medical, TSK Laboratory and Gallini Medical Services are
among the notable players in the global biopsy devices market.
About Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales
Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290
Subscribe to:
Post Comments (Atom)
0 Responses to “Global Biopsy Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022”
Post a Comment